Back to Search

ROBERT VONDERHEIDE, MD

MD

Medical Oncology Physician

NPI: 1902849219Individual

Specialties, Licenses & Credentials

Medical Oncology PhysicianPrimary

Internal Medicine — Medical Oncology

Code: 207RX0202X

MD417436(PA)

Research & Publications (20)

Prospects and challenges of building a cancer vaccine targeting telomerase.
PMID 17716803·Biochimie·2008
6-review
Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody.
PMID 17327609·J Clin Oncol·2007
3-trial
Universal tumor antigens for cancer vaccination: targeting telomerase for immunoprevention.
PMID 18093471·Discov Med·2007
8-other
Prospect of targeting the CD40 pathway for cancer therapy.
PMID 17317815·Clin Cancer Res·2007
6-review
A translational bridge to cancer immunotherapy: exploiting costimulation and target antigens for active and passive T cell immunotherapy.
PMID 12857980·Immunol Res·2003
6-review
Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes.
PMID 14871958·Clin Cancer Res·2004
3-trial
Telomerase as a universal tumor-associated antigen for cancer immunotherapy.
PMID 11850795·Oncogene·2002
6-review
Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals.
PMID 11731409·Cancer Res·2001
8-other
Phase I study of recombinant human CD40 ligand in cancer patients.
PMID 11432896·J Clin Oncol·2001
3-trial
Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase.
PMID 11705846·Clin Cancer Res·2001
8-other
CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity.
PMID 11562757·Int J Oncol·2001
8-other
Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers.
PMID 19549767·Clin Cancer Res·2009
8-other
Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation.
PMID 19602548·Clin Cancer Res·2009
8-other
Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer.
PMID 19013709·Cancer Lett·2009
6-review
Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of Costimulated autologous T cells.
PMID 19509133·Clin Cancer Res·2009
3-trial
Functional analysis of CD8+ T cell responses to the onconeural self protein cdr2 in patients with paraneoplastic cerebellar degeneration.
PMID 18053582·J Neuroimmunol·2008
8-other
Survivin as a universal tumor antigen for novel cancer immunotherapy: functions of a killer clone.
PMID 19158476·Cancer Biol Ther·2008
8-other
Telomerase as a universal tumor antigen for cancer vaccines.
PMID 18767939·Expert Rev Vaccines·2008
6-review
RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma.
PMID 18337841·Gene Ther·2008
7-preclinical
Differential lysis of tumors by polyclonal T cell lines and T cell clones specific for hTERT.
PMID 18087213·Cancer Biol Ther·2007
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
3400 CIVIC CENTER BOULEVARD
PHILADELPHIA, PA 19104

Location

Practice Location

3400 CIVIC CENTER BOULEVARD, PHILADELPHIA, PA
(215) 615-5858

Quick Facts

NPI
1902849219
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile